Deepali Dixit, PharmD, BCPS
Clinical Assistant Professor
Department of Pharmacy Practice and Administration
William Levine Hall, Rm 423
Phone: (848) 445 6827
Specialty: Critical Care
Practice site: Robert Wood Johnson University Medical Center
PharmD,University of Rhode Island
Dr. Dixit is a Clinical Assistant Professor at Ernest Mario School of Pharmacy and a Clinical Critical Care Pharmacist in the Medical Intensive Care Unit at Robert Wood Johnson University Hospital. Dr. Dixit received her Pharmacy degree from University of Rhode Island. Subsequently, Dr. Dixit pursued her post-graduate training in Pharmacy Practice Residency at St. Johns Hospital in Detroit, Michigan and then a Critical Care Pharmacy Specialty Resident at Ernest Mario School of Pharmacy and Robert Wood Johnson University Hospital. Dr. Dixit is a Board Certified Pharmacotherapy Specialist. Dr. Dixit serves as a preceptor for Critical Care Advanced Pharmacy Practice Experiential learning clerkships for Rutgers pharmacy students.
At Robert Wood Johnson University Hospital, Dr. Dixit is intricately involved in direct patient care activities and several interdisciplinary committees. She rounds with the multidisciplinary ICU team, promotes safe use of medications, and intervenes to ensure optimization of pharmacotherapy for her patients. At Ernest Mario School of Pharmacy, Dr. Dixit is coordinator of Poison Management and Drug Abuse and co-coordinates Advanced Pharmacotherapy Applications and is actively involved in several committees. Dr. Dixit has been actively involved in leadership roles in regional and national pharmacy organizations.
Dr. Dixit’s research interests includes sedation and delirium, infectious disease, stroke, chronic obstructive pulmonary disease and patient safety in the ICU.
Chokhavatia S, John E, Bridgeman MB, Dixit D. Constipation in Elderly Patients With Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs and Aging [In Press]
Dixit D, Tobia, A, Chan C, Bury L. Review of Management of Acute Alcohol Syndrome in the Critically Ill. Pharmacotherapy [in Press]
Tawaro T, Yang, A, Dixit D, Bridgeman MB. Management of Hepatic Encephalopathy: A Primer. Ann of Pharmacother 2016 [Ahead of Print Articles] doi:10.1177/1060028016645826.
Chaitman M, Dixit D, Bridgeman MB. Novel Therapeutic Options for the Clinical Management of Hyperkalemia.P&T.2016;41(1):43-50.
Moore K, Dixit D. Wagner M.Topiramate-Related Hyperammonemia. Journal of Pharmacy Technology.2016; 32(1) 34–36
Dixit D, Thomas Z. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Letter to the Editor. Stroke.2015;46:e236, published online before print October 8, DOI: 10.1161/STROKEAHA.115.010997
Dixit D, Bridgeman MB, Barbarello-Andrews L, Narayanan N, Parikh A, Radbel J, Sunderram J. Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD): Diagnosis, Management, and Prevention in the Critically Ill. Pharmacotherapy.2015;35:631-648.
Dixit D, Stewart D,Bridgeman MM, Parikh A. Zonisamide-induced acute kidney injury. Epilepsy and Behavior Case Reports.2015;3:23-25
Dixit D, Kimborowicz K. Pharmacologic Management of Chronic Stable Angina in the Elderly. Journal of the American Academy of Physician Assistants.2015:3:24-32
Dixit D, Patel R, Sharma R.The Role of Tigecycline in the Treatment of Infections in Light of the New Black Box Warning. Expert Review on Anti-Infective Therapy.2014 12(4), 397–400
Dixit D, Shrestha PAdelman M.Neuroleptic Malignant Syndrome Associated with Haloperidol Use in Critical Care Setting. BMJ Case Rep. 2013 Jul 12;2013. pii: bcr2013010133. doi: 10.1136/bcr-2013-010133.